John Harris, MD, PhD, Chair of Dermatology at UMass Chan Medical School, discusses the impact topical ruxolitinib cream has had on patients with vitiligo. He explains how this treatment has shown exceptional efficacy with limited side effects.
Gina Mangin discusses effective treatment practice for patients with vitiligo centered around providing encouragement and motivation throughout the process.
...
Dr. Rosmarin discusses his vitiligo session from November’s Masterclasses in Dermatology Meeting, in which he reviewed recent insights on maintaining and building upon initial treatment response with long-term use of ruxolitinib cream as well as oral JAKs on the horizon for vitiligo.
...
Gina Mangin discusses the importance of educating patients on the expected timeline for repigmentation when utilizing light box therapy.
...
Shanna Miranti speaks to the importance of trying and failing with topical corticosteroids and topical calcineurin inhibitors prior to prescribing patients with topical ruxolitinib.
...
Dr. Elbuluk discusses the importance of assessing the psychological state of patients by gathering social information such as daily activities, living situation, and work status.1 Reference: Disclosures: Expert Perspectives in Vitiligo is supported by InCyte. Dr. Elbuluk has served as a consultant and advisory board member for InCyte. However, the study discussed by Dr. Elbuluk […]
...
